Dr. Michael Caligiuri, director of Ohio State’s Comprehensive Cancer Center and CEO of The James Cancer Hospital and Solove Research Institute, discussed some of his cancer clinical trials and findings.
Dr. Caligiuri’s research lab focuses on research in leukemia, lymphoma and the human immune system. His studies currently include developing a vaccine to prevent lymphoma in organ transplant patients, studying natural killer cell biology, and working to target genetic defects in leukemia and lymphoma for curative therapies. Although most of this research incorporates cancer patients, a good amount of the results can be applied to non-cancer patients–transplant patients, for example.
No comments:
Post a Comment